<DOC>
	<DOCNO>NCT02807428</DOCNO>
	<brief_summary>The objective study evaluate safety analgesic efficacy single preoperative intrathecal administration AYX1 Injection patient undergo unilateral total knee arthroplasty .</brief_summary>
	<brief_title>Study Evaluate Safety/Efficacy Single Preop Dose AYX1 Injection Treat Pain After Knee Replacement Surgery</brief_title>
	<detailed_description>This multi-center , Phase 2 , randomize , double-blind , placebo-controlled study evaluate safety efficacy AYX1 Injection administer intrathecally surgery patient undergo primary unilateral total knee arthroplasty ( TKA ) . Subjects randomize day surgery receive either intrathecal AYX1 Injection intrathecal placebo prior surgery . Study assessment conduct inpatient period 48 hour ; follow-up visit perform Study Day 90 .</detailed_description>
	<criteria>Scheduled undergo primary unilateral TKA spinal anesthesia painful osteoarthritis without congenital knee pathology American Society Anesthesiologists Physical Status Classification System â‰¤ 3 Medically stable determine Investigator base prestudy medical history , physical examination , clinical laboratory test , 12lead electrocardiogram ( ECG ) finding Body Mass Index 1840 kg/m2 Stable medical regimen least 2 week randomization Able read understand study instruction English , willing able comply study procedures More 2 current focal area pain , none great intensity target knee active chronic pain condition would compromise operative knee pain evaluation Inflammatory arthridities ( e.g. , rheumatoid arthritis , lupus , ankylose spondylitis , psoriatic arthritis ) , exception clinically stable/nonactive gout affect knee interfere walk Operative arthroscopy surgical knee last 4 month ( contralateral knee last 2 month ) ; meniscal repair surgical knee last 6 month ( contralateral knee last 3 month ) ; prior surgery either knee last 9 month , except diagnostic arthroscopy ; use cryoneurolysis ( include Iovera ) current operative knee region within 6 month prior randomization and/or time duration study Planned use general anesthesia potent inhalational agent , peripheral nerve block ( e.g. , femoral nerve block ) , neuroaxial ( intrathecal epidural ) opioids , preoperative extend release/long acting opioids , use ketamine preoperatively and/or time duration study Use 40 mg per day ( average ) oral morphine equivalent within 1 month prior randomization Use gabapentin pregabalin within 1 week prior randomization plan use postoperatively Day 28 Use systemic corticosteroid ( include inhale steroid ) within 3 month prior randomization Day 28 ; plan use intraarticular steroid injection time randomization Day 28 Current neurologic disorder , could confound assessment pain ( e.g. , Parkinson 's , Multiple Sclerosis ) Untreated inadequately treat ( opinion Investigator ) active depression Mini Mental State Exam score &lt; 24 screen History alcoholrelated complication within 1 year randomization include , limited , alcoholic withdrawal seizure , hallucination , delirium tremens detoxification treatment Known suspect history illicit drug use within 1 year randomization , current plan use marijuana ( include medical approve use ) within 1 month randomization and/or duration study Any malignancy within past year , exception basal cell carcinoma uncomplicated stable skin cancer document require immediate treatment Women pregnant nursing Previous participation study involve AYX1 Injection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>post-surgical pain</keyword>
	<keyword>total knee arthroplasty</keyword>
	<keyword>total knee replacement</keyword>
</DOC>